Love this game. Build up towards 8 over next two days. Major announcement by end of year - as company announcement of platform partnership deal is being delayed by take-over due diligence. In addition to wishful thinking, I appreciate fast cars, sports, opera and swimming.
Action will take place after Dec options expiry. Caveat - I've never made a correct prediction - but there's always a first for everything...
Stelios Papadopoulos, Ph.D.-- Co-founder and Chairman of Exelixis. (partnership? buyout?) He's Also: *Co-founder & on the BOD of Anadys(ANDS)- up 5% today on expectations of release of prelim Phase 2 data on their Hepatitis C trial-are the results good? partnership discussions?
* Director of Biogen IDEC- they have a bear hug tender offer for Facet Biotech(FACT) that expires today. Will it succeed?
George Scanos-Exelixis CEO He's also: A member of the BOD for Anadys- see above comment
What a position of strength!! Management options are in place. Imagine the phone calls..... Either place your 'reasonable' offer for the whole company or we pursue our new partnership deal with someone else.. sounds reasonable to me. Buckster